Indications
To facilitate tracheal intubation. Also an adjunct to general anesthesia, and for muscle relaxation during surgery or mechanical ventilation.
Contraindications
Skeletal muscle myopathies. Known hypersensitivity to succinylcholine. After the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury. Known or suspected genetic susceptibility to malignant hyperthermia.
Adult dose
Intubation: 0.6 mg/kg IV is the average dose. The best dose varies from 0.3 to 1.1 mg/kg IV. Block starts in about 1 minute, peaks for about 2 minutes, and recovery takes place within 4-6 minutes.
IM, when no vein is available: up to 3-4 mg/kg IM, max total 150 mg. Onset in about 2-3 minutes.
Repeat doses (long procedures): 0.04-0.07 mg/kg IV at intervals after the first IV dose.
Pediatric dose
Emergency intubation: 2 mg/kg IV for infants and small children. 1 mg/kg IV for older children and adolescents.
IM, when no vein is available: up to 3-4 mg/kg IM, max total 150 mg.
Route
IV, IM
Special considerations
Boxed warning: in children with a muscle disease nobody knew about (most often Duchenne), it can cause rhabdomyolysis with hyperkalemia, ventricular dysrhythmias, cardiac arrest and death. So if a healthy-looking child arrests within minutes of the dose, treat for hyperkalemia right away. In children, use it only for emergency intubation, when the airway must be secured right away, or IM when no vein is available.
Hyperkalemia: do not use it after the acute phase of major burns, multiple trauma, extensive denervation or upper motor neuron injury. That risk peaks 7-10 days after the injury. The risk is also higher with electrolyte problems, digitalis toxicity, chronic abdominal infection, subarachnoid hemorrhage, or diseases that degenerate the nerves.
It can trigger malignant hyperthermia. Watch for jaw rigidity, hyperthermia, hypercapnia and tachycardia. If you see it, stop the trigger and give IV dantrolene.
Bradycardia, even asystole, is more common in children and after a second dose. Atropine pretreatment may reduce it.
Many RSI protocols use more than the label's average dose. In the rocuronium label's intubation studies, succinylcholine was given at 1-1.5 mg/kg. Follow your local protocol.
It has no effect on consciousness or pain, so give it after the patient is unconscious, and have intubation, oxygen and ventilation ready first.
It raises pressure in the eye, the skull (briefly) and the stomach. That stomach pressure is why you watch for vomiting and aspiration.
When plasma cholinesterase is low, as after organophosphate insecticide exposure, the block can last much longer.
Follow your local protocols. Sources: FDA drug labels: Quelicin; Rocuronium bromide (Hospira), Clinical Studies. Levels from the National EMS Scope of Practice Model (2019).